Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment.

PLoS One · 2020 · PMC7192484 · PMID 32353063

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

approaching significancep = 0.08so close (0.05 < p ≤ 0.1)

Whereas increased deaths from all leukaemia and all solid cancers are indicated, with hazard ratios (HR) approaching significance, (p = 0.08 and p = 0.26, respectively) the relative risk of death from non-cancer was markedly reduced in the male patients treated with radium compared to controls (HR = 0.81; 95% CI = 0.72–0.91; p = <0.001).

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.